PURA Issues Farmersville Hemp Brand Update Discussing PAOG, ALKM and USMJ Partnerships Including Pharmaceutical, Cryptocurrency And Equity Initiatives
News provided by
Share this article
Share this article
DALLAS, April 20, 2021 /PRNewswire/ Puration, Inc. (USOTC: PURA) today released a management update in conjunction with the recent publication of its FY2021 Annual Report.
PURA entered the cannabis sector in 2015 with the acquisition of a license to extract CBD and THC, among other cannabinoids, from cannabis to include hemp via a U.S. Patented Cannabis Extraction Process.
After experimenting with the business model, PURA introduced EVERx CBD Sports Water and has enjoyed a good deal of success with the sales of EVERx.
USMJ Announces 4/20 Celebration Sale And Now Accepting Cryptocurrency Payments
News provided by
Share this article
Share this article
DALLAS, April 20, 2021 /PRNewswire/ USMJ (North American Cannabis Holdings, Inc.) (USOTC: USMJ) kicks off their yearly 4/20 promotion with a week of sales and celebration for the Cannabis industry. Additionally, USMJ now has the ability to accept Crypto Currencies as a form of payment for exchange of goods.
For the third year in a row, USMJ.com and all its products are on sale. This opportunity isn t exclusive but meant to help out all customers get all of the products they desire.
Recently, USMJ announced a partnership with Wasatch Farms and is now selling their 1500mg CBD and CBG creams, gels and capsules. These high-quality products, made in the U.S.A. help support an American company and the Cannabis industry as a whole.
USMJ Announces 4/20 Celebration Sale And Now Accepting Cryptocurrency Payments prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ USMJ.com (North American Cannabis Holdings, Inc.) (USOTC: USMJ) unveils partnership with Wasatch Hemp Farm out of Utah, U.S.A. American made.
PAO Group, Inc.: PAOG Announces Opportunity To Expand CBD Pharmaceutical Research
Sandusky, Ohio (Newsfile Corp. - April 13, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today released a management update on the company s ongoing CBD Pharmaceutical Development Program.
Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled, METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT.
Since the acquisition, PAOG engaged Veristat, a contract research organization (CRO), dedicated to the clinical advance of therapies and treatments through regulatory approval. PAOG reports Veristat is making substantial progress in validating and supplementing the underlying research behind RespRx.